BG Medicine said today that it has amended its agreement with Abbott Laboratories for licensing and distributing its galectin-3 test. The amendment changes product fees Abbott pays to BG Medicine for galectin-3..

The US Food and Drug Administration (FDA) has granted clearance for Siemens Healthcare's Multitom Rax robotic advanced x-ray system.The new diagnostic imaging system offers a range of examinations in multiple clin..

Teva Pharmaceutical Industries and Heptares will collaborate to develop new Heptares-discovered small-molecule calcitonin gene-related peptide (CGRP) antagonists for migraine, the companies said today. The deal c..

According to MarketsandMarkets, the molecular diagnostics market is estimated to grow at a CAGR of 9.3% to reach USD 9,333.8 Million by 2020. In this report, the molecular diagnostics market is broadly segmente..

The US Food and Drug Administration (FDA) has approved EDDA Technology's new IQQA-Guide, an intra-operative precision 3D navigation system.IQQA-Guide is designed to provide intra-operative precision 3D navigation ..

Want to get noticed at work for all the good reasons and not the bad ones? This will help you achieve your career goals and feel recognized for your hard work. 2.Pay attention to your personal appearance. ..

Dutch molecular diagnostics firm SkylineDx today announced it has received CE-IVD certification for its MMprofiler. The test determines prognosis risk for multiple myeloma patients based on the SKY92 gene signatu..

Blood glucose monitor manufacturers are working to make their data easily accessible and analyzable by patients and healthcare providers. But that's a tall order for this industry segment, which has historically b..

St. Jude Medical announced FDA approval of the Proclaim Elite Spinal Cord Stimulation System to treat chronic back pain.It's the only recharge-free spinal cord stimulation system in its class, at least in the U.S...

GlaxoSmithKline ($GSK) is taking a gamble on Idera Pharmaceuticals' ($IDRA) antisense drug technology, promising up to $100 million in a collaboration focused on renal disease. Under the deal, GSK is paying it..

Vela Diagnostics today announced a collaboration with France's Gustave Roussy Institute of Oncology on next-generation based cancer testing. The collaboration will focus on both solid and liquid tumor diagn..

A group of more than 100 members of the US House of Representatives yesterday signed a letter urging the House Committee on Appropriations work with the US Senate to boost fiscal 2016 funding for the National Institut..

Horizon Discovery has formed a strategic partnership with Axol Bioscience to develop and commercialize genomically modified and differentiated induced pluripotent stem cells (iPSCs) for neuronal and cardiovascular res..

Beckman Coulter Life Sciences and IncellDx have signed a distribution agreement focusing on human papillomavirus and cancer research in China, Hong Kong, and Taiwan. Under the agreement, IncellDx's investig..

Biocept today announced that it has signed two new agreements with preferred provider organization networks — Fortified Provider Network and Three Rivers Provider Network. Under the deals, the approximate..

Recently, Roche acquired Adheron Therapeutics with $580 million for enhancing the immune research. The shareholders of Adheron Therapeutics get $150 million cash, the other $475 million will be paid after they ..

The National Institutes of Health announced that it will commit as much as $40 million over the next seven years to fund the creation of the National Heart, Lung, and Blood Institute Progenitor Cell Translational Cons..

Affymetrix, Inc. (Santa Clara, CA, USA) and XRGenomics LTD (Nottingham, UK) have announced a partnership to collaborate on research and development of a new generation of diagnostic tests for age-related diseases. ..

As the number of drug-resistant superbug infections continues to rise, diagnostics companies are rolling out rapid, point-of-care devices that can quickly identify infectious bacteria and potentially cut down on the n..

Meridian Bioscience announced this week that the US Food and Drug Administration has cleared new claims for the firm's illumigene Pertussis molecular amplification test. The new claims include specimens collected ..